Andrés Celestino
García Montero
Profesor Asociado
Erasmus University Medical Center
Róterdam, HolandaPublicaciones en colaboración con investigadores/as de Erasmus University Medical Center (8)
2017
-
Imatinib in systemic mastocytosis: a phase IV clinical trial in patients lacking exon 17 KIT mutations and review of the literature
Oncotarget, Vol. 8, Núm. 40, pp. 68950-68963
2016
-
Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progression
Leukemia, Vol. 30, Núm. 1, pp. 124-130
-
KIT D816V-mutated bone marrow mesenchymal stem cells in indolent systemic mastocytosis are associated with disease progression
Blood, Vol. 127, Núm. 6, pp. 761-768
2015
-
Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: Diagnostic implications
Modern Pathology, Vol. 28, Núm. 8, pp. 1138-1149
-
Ex vivo identification and characterization of a population of CD13high CD105+ CD45- mesenchymal stem cells in human bone marrow
Stem Cell Research and Therapy, Vol. 6, Núm. 1
-
Phenotypic profile of expanded NK cells in chronic lymphoproliferative disorders: A surrogate marker for NK-cell clonality
Oncotarget, Vol. 6, Núm. 40, pp. 42938-42951
2008
-
Expanded cells in monoclonal TCR-άΒ+/CD4+/NKa+/CD8-/+dim T-LGL lymphocytosis recognize hCMV antigens
Blood, Vol. 112, Núm. 12, pp. 4609-4616
2007
-
Monoclonal TCR-Vβ13.1+/CD4+/NKa +/CD8-/+dim T-LGL lymphocytosis: Evidence for an antigen-driven chronic T-cell stimulation origin
Blood, Vol. 109, Núm. 11, pp. 4890-4898